Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Am J Hematol. 2017 Dec 18;93(3):394–400. doi: 10.1002/ajh.24992

Figure 2.

Figure 2

Event-free survival (A) and overall survival (B) in primary refractory PTCL patients who received traditional, multi-agent salvage regimens (solid line), single-agent salvage regimens (dotted line), and non-systemic therapeutic modalities (dashed line).